658 filings
Page 10 of 33
6-K
a9k0p3rko7mybp2k
13 Jan 20
Immutep Corporate Presentation
10:00am
6-K
8khkydqueec0v eyh8wo
9 Jan 20
Current report (foreign)
6:25am
6-K
qg61d6p7 eppitju
6 Jan 20
Current report (foreign)
10:02am
6-K
5db4o
20 Dec 19
INSIGHT-004 Clinical Trial Update
12:00am
6-K
da6z5zluf
10 Dec 19
Current report (foreign)
6:05am
6-K
67w42b8 h96fbj58
4 Dec 19
Current report (foreign)
6:44am
6-K
65ojzbmkv i2
15 Nov 19
Immutep Announces European Patent Grant for LAG525 Antibody
12:00am
6-K
tvv01bv zq
12 Nov 19
Immutep Presents Positive Interim Data
6:18am
6-K
ieh22g0 wz6y
4 Nov 19
2019 Annual General Meeting
10:02am
EFFECT
92aqrgu4l
31 Oct 19
Notice of effectiveness
12:15am
6-K
ody s6c40
29 Oct 19
TACTI-002 patient recruitment update
12:00am
CORRESP
sjk99ek91yqgs
28 Oct 19
Correspondence with SEC
12:00am
6-K
87qkt7e
23 Oct 19
Quarterly report for entities subject to Listing Rule 4.7B
8:17am
UPLOAD
b0p85p7mxn39
22 Oct 19
Letter from SEC
12:00am
F-3
26ev2ygj
15 Oct 19
Shelf registration (foreign)
4:03pm
6-K
fxlt74xff
15 Oct 19
Immutep Reports Positive Final Efficacy Data fromTACTI-mel Trial
7:30am
6-K
ecxt1 uizfaacb
11 Oct 19
Immutep Announces Data Presentations at Upcoming Industry Conferences
6:06am
6-K
wq58qo8om 4uw7
9 Oct 19
Current report (foreign)
12:00am
6-K
x98lpd
4 Oct 19
Current report (foreign)
12:00am
6-K
hug5k2w
1 Oct 19
Current report (foreign)
9:29am